CRYSTAL STRUCTURE OF A COILED COIL DOMAIN OF HUMAN P160ROCK
人类 P160ROCK 的螺旋线圈域的晶体结构
基本信息
- 批准号:8169314
- 负责人:
- 金额:$ 4.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-04-01 至 2011-03-31
- 项目状态:已结题
- 来源:
- 关键词:ActinsAsthmaBindingCell PolarityCell physiologyCoiled-Coil DomainComputer Retrieval of Information on Scientific Projects DatabaseCytokinesisEukaryotaFilamentFocal AdhesionsFundingGrantHomologous GeneHumanHypertensionInstitutionLightMediatingMicrofilamentsMorphogenesisNeoplasm MetastasisNeuritesPathway interactionsPlayProcessProteinsROCK1 geneResearchResearch PersonnelResourcesRho-associated kinaseRoleSignal TransductionSmooth MuscleSourceStress FibersStructureTumor Cell InvasionUnited States National Institutes of HealthWorkYeastscell motilitydrug developmentrhoyeast protein
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Formins are multidomain proteins that participate in a wide range of cytoskeletal processes. They are required for cell polarity, cell migration, cytokinesis, and morphogenesis in all eukaryotes. The defining feature of formin proteins is the Formin Homology 2 (FH2) domain, which directly nucleates actin filaments and remains processively associated with the barbed end of the filament as it grows.
To better understand how formins work in specific cellular contexts, we are studying a genetically and biochemically well-validated formin partner protein, the yeast protein Bud6. Bud6 is a key binding partner and regulator of the formin Bni1 in yeast.
We have recently determined the structure of a core domain in Bud6 that binds to Bni1 (unpublished). Bud6 has no known human homologs. However, re-examination of a weak similarity in primary sequence between this region of Bud6 and the mammalian protein ROCK1, in light of the structure, suggests that the sequence similarity is reflective of a shared structural and perhaps functional feature in these two proteins.
ROCK (Rho-associated kinase) is an effector of Rho-dependent signaling to mediate stress fibers and focal adhesion formation. It is also involved in many other cellular processes including smooth muscle contraction, cell migration, and neurite outgrowth. Abnormal activation of the Rho-ROCK pathway plays role in tumor invasion and metastasis, hypertension, and bronchial asthma.
A structural and functional parallel between the actin binding domains of Bud6 and human ROCK1 if proven correct will be a breakthrough finding. Their similar structures can be a target for drug development.
这个子项目是众多研究子项目之一
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL J ECK其他文献
MICHAEL J ECK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL J ECK', 18)}}的其他基金
Small molecule inhibitors with a therapeutic window for EGFR signaling variants in glioblastoma
针对胶质母细胞瘤中 EGFR 信号变异具有治疗窗口的小分子抑制剂
- 批准号:
10306230 - 财政年份:2021
- 资助金额:
$ 4.69万 - 项目类别:
Small molecule inhibitors with a therapeutic window for EGFR signaling variants in glioblastoma
针对胶质母细胞瘤中 EGFR 信号变异具有治疗窗口的小分子抑制剂
- 批准号:
10491835 - 财政年份:2021
- 资助金额:
$ 4.69万 - 项目类别:
Structure, mechanism, and pharmacology of BRAF and its partners in the RAS/RAF/MAP kinase pathway
BRAF 及其 RAS/RAF/MAP 激酶通路伙伴的结构、机制和药理学
- 批准号:
9816771 - 财政年份:2019
- 资助金额:
$ 4.69万 - 项目类别:
Structure, mechanism, and pharmacology of BRAF and its partners in the RAS/RAF/MAP kinase pathway
BRAF 及其 RAS/RAF/MAP 激酶通路伙伴的结构、机制和药理学
- 批准号:
10669154 - 财政年份:2019
- 资助金额:
$ 4.69万 - 项目类别:
Structure, mechanism, and pharmacology of BRAF and its partners in the RAS/RAF/MAP kinase pathway
BRAF 及其 RAS/RAF/MAP 激酶通路伙伴的结构、机制和药理学
- 批准号:
10212985 - 财政年份:2019
- 资助金额:
$ 4.69万 - 项目类别:
Structure, mechanism, and pharmacology of BRAF and its partners in the RAS/RAF/MAP kinase pathway
BRAF 及其 RAS/RAF/MAP 激酶通路伙伴的结构、机制和药理学
- 批准号:
10471180 - 财政年份:2019
- 资助金额:
$ 4.69万 - 项目类别:
Discovery and optimization of novel mutant-selective allosteric inhibitors of EGFR T790M
EGFR T790M 新型突变选择性变构抑制剂的发现和优化
- 批准号:
10534760 - 财政年份:2015
- 资助金额:
$ 4.69万 - 项目类别:
Discovery and optimization of novel mutant-selective allosteric inhibitors of EGFR T790M
EGFR T790M 新型突变选择性变构抑制剂的发现和优化
- 批准号:
10316246 - 财政年份:2015
- 资助金额:
$ 4.69万 - 项目类别:
Discovery and optimization of novel mutant-selective allosteric inhibitors of EGFR T790M
EGFR T790M 新型突变选择性变构抑制剂的发现和优化
- 批准号:
9188065 - 财政年份:2015
- 资助金额:
$ 4.69万 - 项目类别:
Structure and regulation of non-receptor tyrosine kinases
非受体酪氨酸激酶的结构和调控
- 批准号:
9247783 - 财政年份:2014
- 资助金额:
$ 4.69万 - 项目类别:
相似海外基金
Defining new asthma phenotypes using high-dimensional data
使用高维数据定义新的哮喘表型
- 批准号:
2901112 - 财政年份:2024
- 资助金额:
$ 4.69万 - 项目类别:
Studentship
Basophilic oncostatin M fuels nociceptor neuron-induced asthma
嗜碱性制瘤素 M 促进伤害感受器神经元诱发哮喘
- 批准号:
485504 - 财政年份:2023
- 资助金额:
$ 4.69万 - 项目类别:
Salary Programs
Engaging Patient and Caregivers in Using Patient-reported Outcomes Measures in Pediatric Clinical Care for Asthma
让患者和护理人员参与儿科哮喘儿科临床护理中患者报告的结果测量
- 批准号:
495593 - 财政年份:2023
- 资助金额:
$ 4.69万 - 项目类别:
Air pollution and Asthma in Canada: Projections of burden and the value of climate adaptation strategies
加拿大的空气污染和哮喘:负担预测和气候适应战略的价值
- 批准号:
485322 - 财政年份:2023
- 资助金额:
$ 4.69万 - 项目类别:
Operating Grants
Data-driven model links BMIz to gene expression in pediatric asthma
数据驱动模型将 BMIz 与小儿哮喘基因表达联系起来
- 批准号:
493135 - 财政年份:2023
- 资助金额:
$ 4.69万 - 项目类别:
BIOlogic drug safety and effectiveness interNational pharmacoepidemiologIC study in pregnant women with autoimmune disorders and asthma and their children (BIONIC)
患有自身免疫性疾病和哮喘的孕妇及其子女的生物药物安全性和有效性国际药物流行病学研究(BIONIC)
- 批准号:
493526 - 财政年份:2023
- 资助金额:
$ 4.69万 - 项目类别:
Operating Grants
A Novel Approach to Target Neutrophilic Airway Inflammation and Airway Hyperresponsiveness in Therapy-Resistant (Refractory) Asthma.
一种针对难治性哮喘中性粒细胞性气道炎症和气道高反应性的新方法。
- 批准号:
10659658 - 财政年份:2023
- 资助金额:
$ 4.69万 - 项目类别:
Treating Maternal Depression in an Urban Community-Based Pediatric Asthma Clinic: Targeting Maternal Mood, Child Asthma Outcomes, and Health Disparities
在城市社区小儿哮喘诊所治疗孕产妇抑郁症:针对孕产妇情绪、儿童哮喘结果和健康差异
- 批准号:
10723233 - 财政年份:2023
- 资助金额:
$ 4.69万 - 项目类别:
Improving Prediction of Asthma-related Outcomes with Genetic Ancestry-informed Lung Function Equations
利用遗传祖先信息的肺功能方程改善哮喘相关结果的预测
- 批准号:
10723861 - 财政年份:2023
- 资助金额:
$ 4.69万 - 项目类别:
Prenatal Fatty Acid Supplementation and Early Childhood Asthma and Atopy in Black American Families
美国黑人家庭产前脂肪酸补充剂与儿童早期哮喘和特应性
- 批准号:
10586398 - 财政年份:2023
- 资助金额:
$ 4.69万 - 项目类别:














{{item.name}}会员




